Continuum Advisory LLC Acquires 949 Shares of Molina Healthcare, Inc (NYSE:MOH)

Continuum Advisory LLC boosted its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 9.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,128 shares of the company's stock after purchasing an additional 949 shares during the period. Continuum Advisory LLC's holdings in Molina Healthcare were worth $3,665,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of MOH. GAMMA Investing LLC lifted its position in shares of Molina Healthcare by 74,593.7% during the 1st quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock valued at $219,708,000 after buying an additional 666,122 shares in the last quarter. Norges Bank purchased a new position in shares of Molina Healthcare during the 4th quarter valued at about $134,675,000. FMR LLC lifted its position in shares of Molina Healthcare by 31.1% during the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after buying an additional 427,276 shares in the last quarter. Voloridge Investment Management LLC lifted its position in shares of Molina Healthcare by 1,641.3% during the 4th quarter. Voloridge Investment Management LLC now owns 409,807 shares of the company's stock valued at $119,274,000 after buying an additional 386,273 shares in the last quarter. Finally, Invesco Ltd. lifted its position in shares of Molina Healthcare by 28.5% during the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock valued at $386,229,000 after buying an additional 294,180 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on MOH. Truist Financial lifted their price objective on Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research report on Friday, April 11th. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and boosted their price target for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. Mizuho boosted their price target on Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Baird R W cut Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Wall Street Zen raised Molina Healthcare from a "hold" rating to a "buy" rating in a report on Saturday. Nine investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $364.21.

Molina Healthcare Price Performance

NYSE:MOH traded up $2.73 during trading hours on Tuesday, reaching $293.87. The stock had a trading volume of 513,887 shares, compared to its average volume of 690,512. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.63 and a current ratio of 1.63. Molina Healthcare, Inc has a 52 week low of $262.32 and a 52 week high of $365.23. The company has a 50 day moving average price of $309.44 and a two-hundred day moving average price of $306.83. The stock has a market capitalization of $15.93 billion, a PE ratio of 14.19, a PEG ratio of 0.98 and a beta of 0.56.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The business had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter in the previous year, the company posted $5.73 EPS. The company's revenue was up 12.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the transaction, the director now owns 11,244 shares of the company's stock, valued at approximately $3,603,702. The trade was a 5.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the transaction, the chief executive officer now directly owns 257,715 shares in the company, valued at approximately $82,484,262.90. This represents a 25.35% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.26% of the company's stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.